Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
Year: 2011
Type: article
Source: Bone
Authors: Paul J. Kostenuik, Susan Y. Smith, Jacquelin Jolette, Joseph Schroeder, Ian Pyrah, Michael S. Ominsky
Institutions: Amgen (United States), Charles River Laboratories (Canada)
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Amgen
OpenAlex ID: W2000100507